Techniker Krankenkasse
16
2
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
Role: collaborator
TeamBaby - Safe, Digitally Supported Communication in Obstetrics and Gynecology
Role: collaborator
Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)
Role: collaborator
Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative Outcome
Role: collaborator
Post-COVID-19 Monitoring in Routine Health Insurance Data
Role: collaborator
Interprofessional Dementia Care
Role: collaborator
Incidence of Diabetes After a COVID-19 Infection
Role: collaborator
Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases
Role: collaborator
Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)
Role: collaborator
Health Care Analysis on Myocardial Revascularization in Patients With Chronic Coronary Heart Disease (CHD)
Role: collaborator
Dialysis Training Therapy: The DiaTT Trial
Role: collaborator
Children of Mentally Ill Parents-Network - CHIMPS-NET
Role: collaborator
Children Affected by Rare Disease and Their Families Network
Role: collaborator
Lifestyle Intervention in Chronic Ischemic Heart Disease and Diabetes
Role: lead
Investigation of a Novel Integrated Care Concept (NICC) for Patients Suffering From Chronic Cardiovascular Disease
Role: collaborator
Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents
Role: collaborator
All 16 trials loaded